SRATI 2022
THE 48TH CONGRESS OF THE ROMANIAN SOCIETY OF ANAESTHESIA AND INTENSIVE CARE
THE 16TH ROMANIAN-FRENCH CONGRESS OF ANAESTHESIA AND INTENSIVE CARE
THE 14TH ROMANIAN-ISRAELI SYMPOSIUM ON UPDATES IN ANAESTHESIA AND INTENSIVE CARE
THE 21ST CONGRESS OF ANAESTHESIA AND INTENSIVE CARE NURSES
THE 9TH SYMPOSIUM OF THE ROMANIAN AND MOLDAVIAN SOCIETIES OF ANAESTHESIA AND INTENSIVE CARE
11 - 15 MAY 2022
HYBRID Event
v-SRATI 2022 Platform & International Conference Center, Sinaia
10, Venezuela Street, 01183
Bucharest, 1st District, Romania
Phone: 0040 - 21 - 202.36. 42
Fax: 0040 - 21 - 231.15.36
We are an international group based in Parma, research-oriented, with over 85 years of experience, present in 30 countries.
The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being).
Chiesi, since 2019, is the world’s largest B Corp certified pharmaceutical group. The global B Corp movement promotes business as a force for good.
Moreover, Chiesi Farmaceutici S.p.A. has changed in 2018 its legal status to a Benefit Corporation, by incorporating a double purpose for the creation of shared value, and to generate value for its business, for society and the environment. The Group is committed to becoming carbon neutral by the end of 2035.
For further information: www.chiesi.com